DIN 02485648 — YESCARTA 200000000 CELLS
YESCARTA is a suspension of Axicabtagene ciloleucel marketed by GILEAD SCIENCES CANADA INC. The full Axicabtagene ciloleucel monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02485648
- Brand name
- YESCARTA
- Active ingredient
- Axicabtagene ciloleucel
- Strength
- 200000000 CELLS
- Dosage form
- SUSPENSION
- Route
- INTRAVENOUS
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- CD19-directed genetically modified autologous T-cell immunotherapy (CAR T-cell therapy)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.